Commercialization And Logistics
-
CTS DynaCellect Fluidics Demonstration
6/9/2025
Streamline and customize your cell processing workflow with automated, precise control over fluid movement and transfer parameters.
-
Thermo Fisher Scientific Customer Experience Center Overview
5/19/2025
Explore cutting-edge single-use technologies with hands-on training at the Customer Experience Center, which is an immersive hub for innovation, learning, and bioprocessing expertise.
-
Thermo Fisher Scientific Single-Use Global Manufacturing Network
4/18/2022
We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.
-
mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A
1/29/2024
During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.
-
Quality Control Assays
11/13/2023
Two company leaders detail not only the vectors their respective companies use and why but also the quality control assays performed on viral vectors.
-
Technology Needs For Automated Manufacturing
8/18/2023
Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.
-
Pipeline Progress
8/18/2023
Experts working on robust pipelines that focus on various therapeutic areas explain how process automation looks different per therapeutic focus area.
-
Supply Chain And Operational Challenges Facing mRNA
1/29/2024
Explore some of the biggest supply chain challenges facing mRNA cancer therapeutics and what short-term solutions may exist, starting with Chain of Custody/Chain of Identity.
-
Optimize Cell Isolation And Activation For Flexibility And Scalability
11/13/2023
Learn about a first-of-its-kind platform technology that enables isolation and activation of T cells in one step using an active release mechanism for clinical trial or commercial manufacturing.
-
CTS OpTmizer One SFM: Thoughtfully Designed Nutrition For T Cells
5/22/2025
Learn about a novel, next-generation medium with an animal-component-free formulation developed to support the need for a T-cell medium that allows consistent, reproducible, and automated T-cell manufacturing.